Dr. Thomas Patterson, Infectious Diseases, was interviewed about the anti-viral drug remdesivir which was recently approbed by the FDA. Clinical trials of the drug began here in March. Dr. Patterson leads our study site, now in its third phase.

Read and watch the story.

The post KENS 5: Remdesivir study underway by UT Health San Antonio and University Health System appeared first on UT Health San Antonio.

Dr. Thomas Patterson, Infectious Diseases, was interviewed about the anti-viral drug remdesivir which was recently approbed by the FDA. Clinical trials of the drug began here in March. Dr. Patterson leads our study site, now in its third phase.

Read and watch the story.

The post KENS 5: Remdesivir study underway by UT Health San Antonio and University Health System appeared first on UT Health San Antonio.